Back
Open Access

How potassium binders can enable RAASi therapy in heart failure.

logo

Session: Clinical case discussion: the value of optimising RAAS inhibition and preserving normokalemia in heart failure
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Doctor M. Kosiborod (Kansas City, US)
Organised by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
55 presentations
10 followers

4 more presentations in this session

Clinical case presentation of a patient with heart failure.

Speaker: Professor P. Van Der Meer (Groningen, NL)

Access
Slides
Video
Like
Thumbnail

The importance of optimal RAASi therapy in heart failure.

Speaker: Professor D. Atar (Oslo, NO)

Access
Slides
Video
Like
Thumbnail

Practical guidance on use of potassium binders in the management of hyperkalemia in heart failure.

Speaker: Doctor C. Bonanad Lozano (Valencia, ES)

Access
Slides
Video
Like
Thumbnail

Panel discussion.

Speaker: Professor P. Van Der Meer (Groningen, NL)

Access
Slides
Video
Like
Thumbnail

Access the full session

Clinical case discussion: the value of optimising RAAS inhibition and preserving normokalemia in heart failure

Speakers: Doctor M. Kosiborod, Professor P. Van Der Meer, Professor D. Atar, Doctor C. Bonanad Lozano, Professor P. Van Der Meer
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources